Trochlear nerve schwannoma with concomitant osimertinib-responsive stage IV lung adenocarcinoma: illustrative case
Osimertinib was effective for lung adenocarcinoma but not for trochlear nerve schwannoma, which required surgical intervention. It is necessary to tailor the treatment of benign brain tumors in patients with concurrent malignant cancers. https://thejns.org/doi/10.3171/CASE24144.
Authors
- Masahiro Tanji (ORCID: https://orcid.org/0009-0002-2459-1856)
- Etsuko Hattori (ORCID: https://orcid.org/0000-0002-2975-774X)
- Yasuhide Takeuchi (ORCID: https://orcid.org/0000-0002-1262-2355)
- Yukinori Terada (ORCID: https://orcid.org/0000-0002-1357-6178)
- Daisuke Natori
- Noritaka Sano (ORCID: https://orcid.org/0000-0002-8999-1976)
- Toshiki Matsuoka
- Hiroaki Ozasa
- Yoshiki Arakawa (ORCID: https://orcid.org/0000-0003-4626-4645)
- Yasuhide Makino
- Shunya Kashiwagi
- Yohei Mineharu
Institutions
- Kyoto University (JP)
- Kishiwada City Hospital (JP)
- Kyoto University Hospital (JP)
Publication Details
- Journal
- Journal of Neurosurgery Case Lessons
- Published
- 2024-08-12
- DOI
- https://doi.org/10.3171/case24144
- Primary Topic
- Neurofibromatosis and Schwannoma Cases
- Type
- article
- Field-Weighted Citation Impact
- 0.00